Location History:
- Wheathampstead, GB (2004 - 2008)
- Hertfordshire, GB (2012)
Company Filing History:
2 out of 17 
1 out of 2 
1 out of 1 Years Active: 2004-2012
Title: David Jack: Innovator in Pharmaceutical Chemistry
Introduction
David Jack is a notable inventor based in Wheathampstead, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target respiratory disorders. With a total of 4 patents to his name, his work has the potential to impact medical treatments significantly.
Latest Patents
Among his latest patents, David Jack has developed derivatives of pyrimido[6,1-A]isoquinolin-4-one. This invention relates to compounds that serve as inhibitors of phosphodiesterase (PDE) isoenzymes. More specifically, these derivatives are being explored for their application in medicine, particularly as bronchodilators with anti-inflammatory properties. The compounds are designed to treat respiratory disorders such as asthma and have shown a longer duration of action compared to existing treatments.
Career Highlights
David Jack has worked with several prominent companies in the pharmaceutical industry, including Verona Pharma Plc and Vernalis Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
One of his notable collaborators is Alexander W Oxford, with whom he has worked on various projects in the field of pharmaceutical research.
Conclusion
David Jack's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key figure in the development of new treatments for respiratory disorders. His work continues to pave the way for advancements in medical science.